These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 24839147)

  • 21. Evaluation of vancomycin target trough attainment with published dosing regimens in the neonatal intensive care unit population.
    Chung E; Lee SE; Abraham T; Saad NN; Gad A
    J Neonatal Perinatal Med; 2019; 12(1):21-27. PubMed ID: 30149480
    [TBL] [Abstract][Full Text] [Related]  

  • 22. External Validation of Model-Based Dosing Guidelines for Vancomycin, Gentamicin, and Tobramycin in Critically Ill Neonates and Children: A Pragmatic Two-Center Study.
    Hartman SJF; Orriëns LB; Zwaag SM; Poel T; de Hoop M; de Wildt SN
    Paediatr Drugs; 2020 Aug; 22(4):433-444. PubMed ID: 32507958
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Vancomycin is commonly under-dosed in critically ill children and neonates.
    Sosnin N; Curtis N; Cranswick N; Chiletti R; Gwee A
    Br J Clin Pharmacol; 2019 Nov; 85(11):2591-2598. PubMed ID: 31378957
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inadequate vancomycin therapy in term and preterm neonates: a retrospective analysis of trough serum concentrations in relation to minimal inhibitory concentrations.
    Sinkeler FS; de Haan TR; Hodiamont CJ; Bijleveld YA; Pajkrt D; Mathôt RA
    BMC Pediatr; 2014 Jul; 14():193. PubMed ID: 25066951
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Vancomycin Dosing Considerations in a Real-World Cohort of Obese and Extremely Obese Patients.
    Morrill HJ; Caffrey AR; Noh E; LaPlante KL
    Pharmacotherapy; 2015 Sep; 35(9):869-75. PubMed ID: 26343549
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Design and validation of a dosing algorithm for vancomycin in premature neonates].
    Juan Aguilar M; Ferriols Lisart R; Tosca Segura R; Alós Almiñana M
    An Pediatr (Barc); 2008 Feb; 68(2):117-23. PubMed ID: 18341876
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Vancomycin population pharmacokinetics in neonates.
    de Hoog M; Schoemaker RC; Mouton JW; van den Anker JN
    Clin Pharmacol Ther; 2000 Apr; 67(4):360-7. PubMed ID: 10801244
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Performance of a divided-load intravenous vancomycin dosing strategy for obese patients.
    Denetclaw TH; Yu MK; Moua M; Dowling TC; Steinke D
    Ann Pharmacother; 2015 Aug; 49(8):861-8. PubMed ID: 25986008
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Assessment of Vancomycin Pharmacokinetics and Dose Regimen Optimisation in Preterm Neonates.
    Mulubwa M; Griesel HA; Mugabo P; Dippenaar R; van Wyk L
    Drugs R D; 2020 Jun; 20(2):105-113. PubMed ID: 32266599
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pharmacokinetics and dose requirements of vancomycin in neonates.
    Grimsley C; Thomson AH
    Arch Dis Child Fetal Neonatal Ed; 1999 Nov; 81(3):F221-7. PubMed ID: 10525029
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The effect of age and weight on vancomycin serum trough concentrations in pediatric patients.
    Madigan T; Sieve RM; Graner KK; Banerjee R
    Pharmacotherapy; 2013 Dec; 33(12):1264-72. PubMed ID: 23864541
    [TBL] [Abstract][Full Text] [Related]  

  • 32. AUC versus peak-trough dosing of vancomycin: applying new pharmacokinetic paradigms to an old drug.
    Brown DL; Lalla CD; Masselink AJ
    Ther Drug Monit; 2013 Aug; 35(4):443-9. PubMed ID: 23851909
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Vancomycin dosing in children and young adults: back to the drawing board.
    Camaione L; Elliott K; Mitchell-Van Steele A; Lomaestro B; Pai MP
    Pharmacotherapy; 2013 Dec; 33(12):1278-87. PubMed ID: 24019205
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Lack of vancomycin-associated nephrotoxicity in newborn infants: a case-control study.
    Bhatt-Mehta V; Schumacher RE; Faix RG; Leady M; Brenner T
    Pediatrics; 1999 Apr; 103(4):e48. PubMed ID: 10103340
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Towards Rational Dosing Algorithms for Vancomycin in Neonates and Infants Based on Population Pharmacokinetic Modeling.
    Janssen EJ; Välitalo PA; Allegaert K; de Cock RF; Simons SH; Sherwin CM; Mouton JW; van den Anker JN; Knibbe CA
    Antimicrob Agents Chemother; 2016 Feb; 60(2):1013-21. PubMed ID: 26643337
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dose regimen for vancomycin not needing serum peak levels?
    Tan WH; Brown N; Kelsall AW; McClure RJ
    Arch Dis Child Fetal Neonatal Ed; 2002 Nov; 87(3):F214-6. PubMed ID: 12390995
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Vancomycin pharmacokinetics and dosing in premature neonates.
    McDougal A; Ling EW; Levine M
    Ther Drug Monit; 1995 Aug; 17(4):319-26. PubMed ID: 7482683
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The pharmacokinetic/pharmacodynamic rationale for administering vancomycin via continuous infusion.
    Waineo MF; Kuhn TC; Brown DL
    J Clin Pharm Ther; 2015 Jun; 40(3):259-65. PubMed ID: 25865426
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Development and external evaluation of a population pharmacokinetic model for continuous and intermittent administration of vancomycin in neonates and infants using prospectively collected data.
    Germovsek E; Osborne L; Gunaratnam F; Lounis SA; Busquets FB; Standing JF; Sinha AK
    J Antimicrob Chemother; 2019 Apr; 74(4):1003-1011. PubMed ID: 30668696
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evaluating the Relationship between Vancomycin Trough Concentration and 24-Hour Area under the Concentration-Time Curve in Neonates.
    Tseng SH; Lim CP; Chen Q; Tang CC; Kong ST; Ho PC
    Antimicrob Agents Chemother; 2018 Apr; 62(4):. PubMed ID: 29358290
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.